ES455933A1 - Procedimiento para la preparacion de nuevos esteroides. - Google Patents
Procedimiento para la preparacion de nuevos esteroides.Info
- Publication number
- ES455933A1 ES455933A1 ES455933A ES455933A ES455933A1 ES 455933 A1 ES455933 A1 ES 455933A1 ES 455933 A ES455933 A ES 455933A ES 455933 A ES455933 A ES 455933A ES 455933 A1 ES455933 A1 ES 455933A1
- Authority
- ES
- Spain
- Prior art keywords
- 6beta
- diene
- bromo
- fluoropregna
- diones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CZZINNLZVMLVDR-BPEVXRFPSA-N (6r,8s,9s,10s,13s,14s,17s)-17-acetyl-2-bromo-6-fluoro-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical class C1([C@H](F)C2)=CC(=O)C(Br)=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1 CZZINNLZVMLVDR-BPEVXRFPSA-N 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento para la preparación de nuevos esteroides, tales como 2-bromo-6beta-fluoro-9alfa-halo-11beta, 17,21-trihidroxi-pregna-1,4-dieno-3-diona y sus 17,21-ésteres y 2-bromo-6beta-fluoruro-9alfa, 11 beta-dihalo-17,21-dihidroxipregna-1,4-dieno-3,20-diona y sus 17,21-ésteres, 17,21-alquilortoésteres y 17,21-acetales cíclicos de fórmula (A). ***
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8928/74A GB1499822A (en) | 1974-02-27 | 1974-02-27 | 2-bromo-6beta-fluoropregna-1,4-diene-3,20-diones |
GB2998474 | 1974-07-05 | ||
GB3294574 | 1974-07-25 | ||
GB4998274 | 1974-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES455933A1 true ES455933A1 (es) | 1978-05-01 |
Family
ID=27447687
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES435067A Expired ES435067A1 (es) | 1974-02-27 | 1975-02-25 | Procedimiento para la preparacion de nuevos esteroides. |
ES455933A Expired ES455933A1 (es) | 1974-02-27 | 1977-02-15 | Procedimiento para la preparacion de nuevos esteroides. |
ES455934A Expired ES455934A1 (es) | 1974-02-27 | 1977-02-15 | Procedimiento para la preparacion de nuevos esteroides. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES435067A Expired ES435067A1 (es) | 1974-02-27 | 1975-02-25 | Procedimiento para la preparacion de nuevos esteroides. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES455934A Expired ES455934A1 (es) | 1974-02-27 | 1977-02-15 | Procedimiento para la preparacion de nuevos esteroides. |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5614677B2 (es) |
AR (1) | AR218601A1 (es) |
BE (1) | BE826030A (es) |
CA (1) | CA1064476A (es) |
CH (1) | CH608243A5 (es) |
DE (3) | DE2508136C3 (es) |
DK (1) | DK144068C (es) |
ES (3) | ES435067A1 (es) |
FI (1) | FI56188C (es) |
FR (1) | FR2261776B1 (es) |
GB (1) | GB1499822A (es) |
IE (1) | IE42112B1 (es) |
LU (1) | LU71908A1 (es) |
NO (1) | NO144527C (es) |
NZ (1) | NZ176716A (es) |
RO (1) | RO78881A (es) |
SE (1) | SE410736B (es) |
YU (3) | YU108381A (es) |
-
1974
- 1974-02-27 GB GB8928/74A patent/GB1499822A/en not_active Expired
-
1975
- 1975-02-10 CA CA219,681A patent/CA1064476A/en not_active Expired
- 1975-02-14 FR FR7504616A patent/FR2261776B1/fr not_active Expired
- 1975-02-19 DK DK61575A patent/DK144068C/da not_active IP Right Cessation
- 1975-02-20 NZ NZ176716A patent/NZ176716A/xx unknown
- 1975-02-24 IE IE379/75A patent/IE42112B1/en unknown
- 1975-02-24 AR AR257732A patent/AR218601A1/es active
- 1975-02-25 CH CH232575A patent/CH608243A5/xx not_active IP Right Cessation
- 1975-02-25 LU LU71908A patent/LU71908A1/xx unknown
- 1975-02-25 ES ES435067A patent/ES435067A1/es not_active Expired
- 1975-02-25 NO NO750633A patent/NO144527C/no unknown
- 1975-02-25 DE DE2508136A patent/DE2508136C3/de not_active Expired
- 1975-02-25 FI FI750537A patent/FI56188C/fi not_active IP Right Cessation
- 1975-02-26 RO RO7581496A patent/RO78881A/ro unknown
- 1975-02-26 BE BE153787A patent/BE826030A/xx not_active IP Right Cessation
- 1975-02-26 JP JP2298075A patent/JPS5614677B2/ja not_active Expired
- 1975-02-26 SE SE7502146A patent/SE410736B/xx unknown
- 1975-07-25 DE DE2533323A patent/DE2533323C3/de not_active Expired
- 1975-07-25 DE DE2533377A patent/DE2533377C3/de not_active Expired
-
1977
- 1977-02-15 ES ES455933A patent/ES455933A1/es not_active Expired
- 1977-02-15 ES ES455934A patent/ES455934A1/es not_active Expired
-
1981
- 1981-04-27 YU YU01083/81A patent/YU108381A/xx unknown
- 1981-04-27 YU YU01084/81A patent/YU108481A/xx unknown
- 1981-04-27 YU YU01082/81A patent/YU108281A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA755553B (en) | Anti-inflammatory steroids of the androstane series | |
ES455933A1 (es) | Procedimiento para la preparacion de nuevos esteroides. | |
IL39821A0 (en) | 21-esters of 11,17,21-trihydroxy-pregna-1,4-diene-3,20-dione derivatives | |
DK129039B (da) | Fremgangsmåde til fremstilling af 11β,16α17α21-tetrahydroxy-pregna-1,4-dien-3,20-dioner eller de tilsvarende 16,17-acetonider. | |
GB1536875A (en) | Process for the manufacture of oestrene-3,17-dione derivatives | |
BG33735A3 (bg) | Метод за получаване на заместени в 17-та позиция стероиди от прегнановия ред | |
CA1035351A (en) | Process for producing cholestane type steroid | |
CA1034521A (en) | PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES | |
ES316376A1 (es) | Un procedimiento para la preparacion de 3-espiro-3-diazirinaesteroides. | |
ES444231A1 (es) | Procedimiento para la preparacion de esteres del acido (1- bencil-1h-indazoil-3-il)-oxi)-acetico. | |
GB983125A (en) | Preparation of 9(11)-dehydro spirostanes and 3-esters thereof | |
ES465550A1 (es) | Procedimiento para la obtencion de halogenopregnadienos. | |
AT272536B (de) | Verfahren zur Herstellung von Androsta-1,4-dien-3,17-dion | |
GB1008273A (es) | ||
NL7511830A (nl) | Werkwijze voor de bereiding van 13(beta)-alkyl-4-go- neen-3,17-dionen. | |
ES306437A1 (es) | Un procedimiento para la preparacion de 3-espiro-3-diazirinaesteroides o 3-espiro-3-diaziridina esteroides. | |
ES319114A1 (es) | Un procedimiento de preparacion de los 21-hidroxi esteroides de la serie del pregnano esterificados en la posicion 21. | |
AU8287275A (en) | Haptene steroids derived from progesterone | |
DK103018C (da) | Fremgangsmåde til fremstilling af 3-keto-Δ<4,6>-steroider af androstan- eller pregnanrækken. | |
GB1096958A (en) | Improvements in or relating to 9ª,10ª-steroid compounds | |
ES388784A1 (es) | Un procedimiento de preparacion de la 17 alfa - hidroxi - pregna - 4,9 (11)-dieno - 3,20 - diona. | |
IL46751A (en) | 2-bromo-6-9difluoro-11-hydroxy-pregna-1,4-diene-3,20-diones and process for their preparation | |
GB1515664A (en) | Derivatives of 17alpha-hydroxy-19-norpregn-4-ene-3,20-dione | |
DK140900B (da) | Analogifremgangsmåde til fremstilling af D-homopregna-1,4-dien-3,11,20-trioner. | |
ES307265A1 (es) | Un procedimiento de preparacion de 21-diciclohexilmetil-carbonatos de esteroides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19971001 |